For Now, HRSA Doesn’t Plan to Change Its April 340B Registration Period
With health care providers bracing for COVID-19’s full force, the Health Resources and Services Administration (HRSA) at this time does not plan
…Category: Regulatory
HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly
The Health Resources and Services Administration (HRSA) is advising health care providers concerned about whether
…Editor’s note: The Medicare Payment Advisory Commission (MedPAC) is expected to report to Congress tomorrow that 340B’s effects on Medicare Part B beneficiaries’ cost sharing is likely small and varied across patients. We’ll publish an article about the findings and
…
Hospital Groups to OMB: Quash 340B Hospital Drug Acquisition Cost Survey
Groups representing 340B hospitals urged the White House yesterday to quash a planned survey due to
…
DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges
The U.S. Justice Department is suing drug manufacturer Mallinckrodt for allegedly
…
340B Providers Could Face Drug Access Challenges Due to Coronavirus
In theory, federal law and 340B program guidance should protect 340B entities from shouldering an unfair
…Editors’ note: Have you read our 13-page special report on the 340B Coalition Winter Conference? We’ve received excellent feedback and think you and your colleagues will find it beneficial. Let us know what you think. Write to us at
Drug manufacturers are doing a better job of providing the Health Resources and Services Administration (HRSA) with timely and accurate data needed to verify their 340B ceiling prices, the head of the federal 340B drug pricing program indicated today. Nonetheless,
…The Trump administration today asked Congress again to require 340B covered entities to report their 340B program savings and uses to the Health Resources and Services Administration (HRSA).
The administration made the request in its proposed federal budget for fiscal
…CMS Takes Another Step Toward Collecting Hospitals’ 340B Acquisition Costs
The Centers for Medicare & Medicaid Services (CMS) has taken another step toward requiring hospitals to let it see their 340B drug acquisition costs so CMS can base the hospitals’
…